Viyash Scientific Limited (BOM:512529)
252.50
-3.10 (-1.21%)
At close: Aug 17, 2026
Viyash Scientific Revenue
Viyash Scientific had revenue of 9.46B INR in the quarter ending June 30, 2026, with 114.39% growth. This brings the company's revenue in the last twelve months to 35.75B, up 123.08% year-over-year. In the fiscal year ending March 31, 2026, Viyash Scientific had annual revenue of 34.20B with 13.75% growth.
Revenue (ttm)
35.75B
Revenue Growth
+123.08%
P/S Ratio
3.08
Revenue / Employee
12.33M
Employees
2,900
Market Cap
110.21B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 34.20B | 4.13B | 13.75% |
| Mar 31, 2025 | 30.07B | 16.37B | 119.52% |
| Mar 31, 2024 | 13.70B | -511.78M | -3.60% |
| Mar 31, 2023 | 14.21B | 80.93M | 0.57% |
| Mar 31, 2022 | 14.13B | 512.01M | 3.76% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Jubilant Pharmova | 86.08B |
| Granules India | 56.32B |
| AstraZeneca Pharma India | 24.32B |
| Caplin Point Laboratories | 22.87B |
| FDC Limited | 21.90B |
| Morepen Laboratories | 19.51B |
| Sanofi India | 18.05B |
| Rubicon Research | 17.54B |
Viyash Scientific News
- 5 days ago - Viyash Scientific Transcript: Q1 26/27 - Transcripts
- 5 days ago - Viyash Scientific Quarterly report: Q1 2027 - Filings
- 5 days ago - Viyash Scientific Slides: Q1 2027 - Filings
- 7 weeks ago - Viyash Scientific Slides: FY 2026 - Filings
- 3 months ago - Viyash Scientific Transcript: Q4 25/26 - Transcripts
- 3 months ago - Viyash Scientific Slides: Q4 2026 - Filings
- 3 months ago - Viyash Scientific Quarterly report: Q4 2026 - Filings
- 3 months ago - Viyash Scientific Annual report: Q4 2026 - Filings